Trial intelligence / Profile preview

Januvia vs Thiazolidinediones in Type 2 Diabetes

NCT00686634Phase 4Completed

Sponsor
Charles Drew University of Medicine & Science
Start
Jan 2008
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Charles Drew University of Medicine & Science. Started Jan 2008; status: completed.

02

Drugs

sitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00686634.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00686634.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call